Titan Pharmaceuticals, Inc. Stock Split Ratio
Titan Pharmaceuticals, Inc. reported Stock Split Ratio of 3.33% for the 1-month period ending 2020-11-30, per its 10-K filed 2022-03-25.
Discontinued › Notes › Equity › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2022-03-25
- 2020-11-30: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 3.33%.
- 2019-01-31: Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month 16.67%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio 1 month |
|---|---|
| 2020-11-30 | 3.33% 10-K · filed 2022-03-25 |
| 2019-01-31 | 16.67% 10-K · filed 2020-03-30 |